These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34614012)

  • 1. A descriptive study of healthcare-providers' experiences with the use and quality of oxytocin for the prevention of post-partum hemorrhage in Nigeria: A nation-wide survey.
    Ejekam CS; Nyangara FM; Anyakora C; Nwokike J
    PLoS One; 2021; 16(10):e0258096. PubMed ID: 34614012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experiences with the use of oxytocin injection by healthcare providers in a southwestern state of Nigeria: A cross-sectional study.
    Ejekam CS; Okafor IP; Anyakora C; Ozomata EA; Okunade K; Oridota SE; Nwokike J
    PLoS One; 2019; 14(10):e0208367. PubMed ID: 31600195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage.
    Shrestha A; Dongol A; Chawla CD; Adhikari RK
    Kathmandu Univ Med J (KUMJ); 2011; 9(33):8-12. PubMed ID: 22610801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of oxytocin use for induction and augmentation of labour among healthcare providers in Nigeria.
    Ejekam CS; Okafor IP; Okunade KS; Igbokwe U; Nwokike J
    BMC Pregnancy Childbirth; 2024 Jun; 24(1):403. PubMed ID: 38824569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare providers' knowledge and practices associated with postpartum hemorrhage during facility delivery in Dar es Salaam, Tanzania.
    Carnahan LR; Geller SE; Leshabari S; Sangu W; Hanselman B; Patil CL
    Int J Gynaecol Obstet; 2016 Dec; 135(3):268-271. PubMed ID: 27569024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of hospital care of women with postpartum haemorrhage in India, Kenya, Nigeria and Uganda: a financial case for improved prevention.
    Theunissen F; Cleps I; Goudar S; Qureshi Z; Owa OO; Mugerwa K; Piaggio G; Gülmezoglu AM; Nakalembe M; Byamugisha J; Osoti A; Mandeep S; Poriot T; Gwako G; Vernekar S; Widmer M
    Reprod Health; 2021 Jan; 18(1):18. PubMed ID: 33482858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
    Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
    Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.
    Priya GP; Veena P; Chaturvedula L; Subitha L
    Arch Gynecol Obstet; 2015 Dec; 292(6):1231-7. PubMed ID: 25990482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing at-scale, community-based distribution of misoprostol tablets to mothers in the third stage of labor for the prevention of postpartum haemorrhage in Sokoto State, Nigeria: Early results and lessons learned.
    Orobaton N; Abdulazeez J; Abegunde D; Shoretire K; Maishanu A; Ikoro N; Fapohunda B; Balami W; Beal K; Ganiyu A; Gwamzhi R; Austin A
    PLoS One; 2017; 12(2):e0170739. PubMed ID: 28234894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability.
    Kibira D; Ooms GI; van den Ham HA; Namugambe JS; Reed T; Leufkens HG; Mantel-Teeuwisse A
    BMJ Open; 2021 Jan; 11(1):e042948. PubMed ID: 33414148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of sublingual misoprostol as first-line treatment for primary post-partum hemorrhage: results of a multicenter trial.
    Okonofua FE; Ogu RN; Akuse JT; Ujah IA; Galadanci HS; Fabamwo AO
    J Obstet Gynaecol Res; 2014 Mar; 40(3):718-22. PubMed ID: 24320203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.
    Leduc D; Senikas V; Lalonde AB;
    J Obstet Gynaecol Can; 2009 Oct; 31(10):980-993. PubMed ID: 19941729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of prophylactic uterotonics during the third stage of labor: a survey of provider practices in community health facilities in Sierra Leone.
    Natarajan A; Ahn R; Nelson BD; Eckardt M; Kamara J; Kargbo S; Kanu P; Burke TF
    BMC Pregnancy Childbirth; 2016 Jan; 16():23. PubMed ID: 26821645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
    Chaudhuri P; Mandi S; Mazumdar A
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan.
    Abbas DF; Mirzazada S; Durocher J; Pamiri S; Byrne ME; Winikoff B
    Reprod Health; 2020 Jun; 17(1):88. PubMed ID: 32503556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Per Rectal Misoprostol Versus Intramuscular Oxytocin for Prevention of Primary Postpartum Haemorrhage.
    Asmat R; Ashraf T; Asmat F; Asmat S; Asmat N
    J Coll Physicians Surg Pak; 2017 Jan; 27(1):13-17. PubMed ID: 28292361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage.
    Lokugamage AU; Sullivan KR; Niculescu I; Tigere P; Onyangunga F; El Refaey H; Moodley J; Rodeck CH
    Acta Obstet Gynecol Scand; 2001 Sep; 80(9):835-9. PubMed ID: 11531635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the operational feasibility and acceptability of an inhalable formulation of oxytocin for improving community-based prevention of postpartum haemorrhage in Myanmar: a qualitative inquiry.
    Than KK; Oliver V; Mohamed Y; La T; Lambert P; McIntosh M; Luchters S
    BMJ Open; 2018 Oct; 8(10):e022140. PubMed ID: 30361400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
    Tewatia R; Rani S; Srivastav U; Makhija B
    Arch Gynecol Obstet; 2014 Apr; 289(4):739-42. PubMed ID: 24045979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?
    Lovold A; Stanton C; Armbruster D
    Int J Gynaecol Obstet; 2008 Dec; 103(3):276-82. PubMed ID: 18954869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.